Sceneray Co. Ltd, located at Singapore Industrial Park in Suzhou China, is a medical device company dedicated to the design, development, and distribution of neuromodulation devices. The core team of Sceneray is made up by experts with deep China and overseas experiences in neuromodulation device development, manufacturing, and marketing. Sceneray holds many patents and keeps on exploring the frontiers in neuromodulation. Being an international high-tech medical and competitive company, Sceneray is dedicated to providing patients with high-quality and efficacious treatments.

National University Corp. Tokyo Medical & Dental University is a private company headquartered in Japan that operates as an national educational institution for dentistry.

Manufactures pharmaceuticals

Barricaid develops a bone-anchored implant that reduces the incidence of reherniation and reoperation in patients with large annular defects. It is designed to prevent reherniation by physically blocking the annulus at the post-surgery defect. The anchor component is comprised of titanium alloy that is placed into either the caudal or cranial-adjacent vertebral body to secure the device in position.

Gachon University Gil Medical Center is a South Korean private company. The firm operates as medical center.

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

Shanghai New Helium Brain-like Intelligence Technology Co., Ltd., established on 2017-11-13, Business scope includes smart technology,Internet technology,electronic technology,Information Technology,Biological Technology,Technology development in the field of medical technology,technical consulting,Technical Services,technology transfer,Computer Information System Integration,Industrial Product Design,design,make,acting,Place an ad,property management,Maker space management,Business Management Consulting,Financial Advisory,business inquiries,Legal advice,Own Equipment Rental,Exhibition display service,account Serive,creative services,Intellectual property agency,Computer hardware and software and auxiliary equipment,electronic Materials,Development of electronic components,Sales,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Agouron Pharmaceuticals, Inc.’s operations consists of the discovery, development, manufacture, and marketing of therapeutic products engineered to inactivate proteins, which play roles in cancer, AIDS, and other serious diseases. Its product, VIRACEPT®, was a drug for the treatment of HIV infection. Agouron Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Shanghai Kunmeng Biotechnology Co., Ltd., established on 2019-09-12, Business scope includes biotechnology(genetically modified organism,Except human stem cell genetic diagnosis),Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer,translation service,account Serive,Sales of laboratory equipment and consumables,Instrumentation,Equipment,Office Equipment and Supplies,Plastic products,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Lianying Zhirong Medical Technology Co., Ltd., established on 2019-02-27, Business scope includes licensed projects:Production of Class III Medical Devices;Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;medical service;Internet Information Service for Medical Devices;Construction Engineering Construction(In addition to the construction and operation of nuclear power plants,Civil Airport Construction);Construction engineering design;Construction labor subcontracting(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Sales of Class II Medical Devices;Additive Manufacturing Equipment Manufacturing;Manufacturing of electronic components;Electronic special material manufacturing;Manufacturing of computer software, hardware and peripheral equipment;Class II Medical Device Leasing;Production of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class I Medical Devices;software development;Information system integration service;Information Technology Consulting Services;Computer System Services;Information Consulting Service(Not including licensing information consulting services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Mechanical equipment research and development;Research and development of intelligent robots;Research and development of special electronic materials;Machinery sales;Mechanical Parts,Parts sales;electronics sales;software sales;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Shanghai Xiaoshen Biotechnology Co., Ltd., established on 2020-10-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Conference and Exhibition Services;translation service;Experimental analysis instrument sales;Retailing of computer software, hardware and auxiliary equipment;Instrument sales;Machinery sales;Office Supplies Sales;Sales of plastic products;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom.